The heparin problem is no longer a discrete, well-defined mess. Regulators in Germany announced that Chinese-sourced heparin sold in that country has been linked to two outbreaks of allergic reactions. The good news: The number of patients involved is less than 100, and none has died. The bad: The suspect heparin was not made by Baxter, and its active ingredient, though originating in China, was not processed by Baxter's API supplier.
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Comments